High Ki-67 expression is correlated with increased cell proliferation and is commonly found in aggressive breast cancer subtypes, such as luminal B, HER2-positive, and triple-negative (basal-like) cancers [16,17]. Here, ERBB2 is linked to breast carcinoma.